Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Linder

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 19, 2012
No GGGGCC-hexanucleotide repeat expansion in C9ORF72 in parkinsonism patients in SwedenChizuru Akimoto, Lars Forsgren, Jan Linder, et al.
Neurology|November 2, 2018
Early predictors of mortality in parkinsonism and Parkinson disease: A population-based studyDavid Bäckström, Gabriel Granåsen, Magdalena Eriksson Domellöf, et al.
JAMA Neurology|August 11, 2015
Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson DiseaseDavid C Bäckström, Magdalena Eriksson Domellöf, Jan Linder, et al.
Journal of Parkinson'S Disease|August 14, 2013
Plasma-based circulating MicroRNA biomarkers for Parkinson's diseaseSok Kean Khoo, David Petillo, Un Jung Kang, et al.
Journal of Parkinson'S Disease|June 15, 2014
Metabolite and peptide levels in plasma and CSF differentiating healthy controls from patients with newly diagnosed Parkinson's diseaseMiles Trupp, Pär Jonsson, Annika Öhrfelt, et al.
Neurology|February 10, 2017
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorderOskar Hansson, Shorena Janelidze, Sara Hall, et al.
EJNMMI Research|November 17, 2018
Dopamine transporter imaging with [<sup>18</sup>F]FE-PE2I PET and [<sup>123</sup>I]FP-CIT SPECT-a clinical comparisonSusanna Jakobson Mo, Jan Axelsson, Lars Jonasson, et al.
Parkinsonism & Related Disorders|June 20, 2016
Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costsSven E Pålhagen, Olof Sydow, Anders Johansson, et al.
Journal of Human Genetics|April 10, 2015
Fine mapping and resequencing of the PARK16 locus in Parkinson's diseaseLasse Pihlstrøm, Aina Rengmark, Kari Anne Bjørnarå, et al.
Neurobiology of Aging|November 17, 2012
Supportive evidence for 11 loci from genome-wide association studies in Parkinson's diseaseLasse Pihlstrøm, Gunnar Axelsson, Kari Anne Bjørnarå, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 19, 2012
No GGGGCC-hexanucleotide repeat expansion in C9ORF72 in parkinsonism patients in SwedenChizuru Akimoto, Lars Forsgren, Jan Linder, et al.
Neurology|November 2, 2018
Early predictors of mortality in parkinsonism and Parkinson disease: A population-based studyDavid Bäckström, Gabriel Granåsen, Magdalena Eriksson Domellöf, et al.
JAMA Neurology|August 11, 2015
Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson DiseaseDavid C Bäckström, Magdalena Eriksson Domellöf, Jan Linder, et al.
Journal of Parkinson'S Disease|August 14, 2013
Plasma-based circulating MicroRNA biomarkers for Parkinson's diseaseSok Kean Khoo, David Petillo, Un Jung Kang, et al.
Journal of Parkinson'S Disease|June 15, 2014
Metabolite and peptide levels in plasma and CSF differentiating healthy controls from patients with newly diagnosed Parkinson's diseaseMiles Trupp, Pär Jonsson, Annika Öhrfelt, et al.
Neurology|February 10, 2017
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorderOskar Hansson, Shorena Janelidze, Sara Hall, et al.
EJNMMI Research|November 17, 2018
Dopamine transporter imaging with [<sup>18</sup>F]FE-PE2I PET and [<sup>123</sup>I]FP-CIT SPECT-a clinical comparisonSusanna Jakobson Mo, Jan Axelsson, Lars Jonasson, et al.
Parkinsonism & Related Disorders|June 20, 2016
Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costsSven E Pålhagen, Olof Sydow, Anders Johansson, et al.
Journal of Human Genetics|April 10, 2015
Fine mapping and resequencing of the PARK16 locus in Parkinson's diseaseLasse Pihlstrøm, Aina Rengmark, Kari Anne Bjørnarå, et al.
Neurobiology of Aging|November 17, 2012
Supportive evidence for 11 loci from genome-wide association studies in Parkinson's diseaseLasse Pihlstrøm, Gunnar Axelsson, Kari Anne Bjørnarå, et al.
Pageof 6